3. Summary
Global Markets Direct’s, Post-Traumatic Stress Disorder (PTSD) - Pipeline
Review, H2 2012, provides an overview of the indication’s therapeutic pipeline.
This report provides information on the therapeutic development for Post-
Traumatic Stress Disorder (PTSD), complete with latest updates, and special
features on late-stage and discontinued projects. It also reviews key players
involved in the therapeutic development for Post-Traumatic Stress Disorder
(PTSD). Post-Traumatic Stress Disorder (PTSD) - Pipeline Review, Half Year is
built using data and information sourced from Global Markets Direct’s
proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s
team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
4. Scope
- A snapshot of the global therapeutic scenario for Post-Traumatic Stress Disorder
(PTSD).
- A review of the Post-Traumatic Stress Disorder (PTSD) products under
development by companies and universities/research institutes based on
information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.
Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Post-Traumatic Stress Disorder (PTSD).
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
5. Table of Contents :
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Post-Traumatic Stress Disorder (PTSD) Overview 8
Therapeutics Development 9
An Overview of Pipeline Products for Post-Traumatic Stress Disorder (PTSD)
9
Post-Traumatic Stress Disorder (PTSD) Therapeutics under Development by
Companies 11
Post-Traumatic Stress Disorder (PTSD) Therapeutics under Investigation by
Universities/Institutes 13
Late Stage Products 15
Comparative Analysis 15
Mid Clinical Stage Products 16
Comparative Analysis 16
Early Clinical Stage Products 17
Comparative Analysis 17
Pre-Clinical Stage Products 18
Comparative Analysis 18
Post-Traumatic Stress Disorder (PTSD) Therapeutics – Products under
Development by Companies 19……………………………..
6. Please follow link if you want More Related
Reports :
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?searc
h=Pipeline Review, H2 2012&PubId=&pagenum=1